Bristol-Myers Squib
Executive Summary
Michael Loberg, PhD, to president of Bristol-Myers Squibb Specialty Pharmaceutical Products Group. The appointment became effective June 1. Loberg reports to BMS U.S. Pharmaceutical Group President Bruce Ross. Reporting to Loberg will be Mead Johnson VP and General Manager Donald Hayden; Westwood-Squibb Pharmaceuticals President Jeffery March; and Apothecon VP and General Manager Lee Burg.